KAPADI

DEAD

Serial Number

98297884

Owner

OncoBay Clinical, Inc.

Attorney

Philip J. Cardinale

Filing Date

Dec 4, 2023

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

KAPADI Trademark

Serial Number: 98297884

KAPADI is a trademark filed by OncoBay Clinical, Inc. on December 4, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently no longer active.

Trademark Classes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

OncoBay Clinical, Inc. (4 trademarks)

10902 McKinley Drive
Tampa, FL 33612

Entity Type: 03

Legal Representation

Attorney of Record

Philip J. Cardinale

1,025 trademarks filed View all →

Correspondence Address

Philip J. Cardinale SMITH ANDERSON BLOUNT DORSETT MITCHEL & JERNIGAN LLP

150 Fayetteville Street, Suite 2300

Raleigh, NC 27601

United States

Trademark Details

Filing Date

December 4, 2023

Registration Date

Not Registered

Published for Opposition

February 4, 2025

Goods & Services

Research and development of biopharmaceuticals, biologic assays in the nature of biopharmaceuticals

Consulting services in the field of medical product approval for commercial purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Nov 3, 2025 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Nov 3, 2025 ABN6

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 1, 2025 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Feb 4, 2025 NPUB

PUBLISHED FOR OPPOSITION

Feb 4, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jan 29, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 16, 2025 CNSA

EXAMINER'S AMENDMENT ENTERED

Jan 16, 2025 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jan 16, 2025 GNEN

EXAMINERS AMENDMENT E-MAILED

Jan 16, 2025 GNEA

EXAMINERS AMENDMENT -WRITTEN

Jan 16, 2025 CNEA

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

Sep 20, 2024 XELG

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

Sep 20, 2024 XELR

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 2, 2024 GNRN

NON-FINAL ACTION E-MAILED

Jul 2, 2024 GNRT

NON-FINAL ACTION WRITTEN

Jul 2, 2024 CNRT

ASSIGNED TO EXAMINER

Jul 1, 2024 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 28, 2024 NWOS

NEW APPLICATION ENTERED

Dec 4, 2023 NWAP

Related Trademarks

More from this Owner

K KAPADI

ONCOBAY CLINICAL

More in Same Class

THE NEW AMERICAN REMODEL

Serial #98297935

MEGAE

AGENCYREMIX

FASTSPRING

INEXPORT LOGISTICS